Volume 12, Number 2—February 2006
Research
Methicillin-resistant Staphylococcus aureus Clones, Western Australia
Table 1
Clone | CHEF pattern (pulsotypes) | n (% of total MRSA) | CC | Urease | Coagulase PCR RFLP pattern | PVL toxin |
---|---|---|---|---|---|---|
ST22-MRSA-IV | EMRSA-15 | 719 (17.54) | 22 | Neg | 22 | Neg |
ST239-MRSA-III | Aus-2 EMRSA | 95 (2.32) | 8 | Pos | 24 | Neg |
Aus-3 EMRSA | 57 (1.39) | 8 | Pos | 24 | Neg | |
ST8-MRSA-IVp | Irish-2 EMRSA | 20 (0.49) | 8 | Neg | 18 | Neg |
ST36-MRSA-II | EMRSA-16 | 16 (0.39) | 30 | Pos | 18 | Neg |
ST5-MRSA-II | New York/Japan EMRSA | 11 (0.27) | 5 | Pos | 36 | Neg |
ST8-MRSA-IIv | Irish-1 EMRSA | 2 (0.05) | 8 | Neg | 18 | Neg |
ST250-MRSA-I | Classic MRSA | 1 (0.02) | 8 | Pos | 18 | Neg |
Total | 921 (22.47) |
*EMRSA, epidemic methicillin-resistant Staphylococcus aureus; CHEF, contour-clamped homogeneous electric field; CC, clonal complex; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphisms; PVL, Panton-Valentine leukocidin; MRSA, methicillin-resistant S. aureus; p, pediatric; v, variant.
Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.